PDRN, Polynucleotides and Salmon DNA: Are They the Same?

Skincare menus may put several labels together: PDRN facial, polynucleotides, PN, “salmon DNA” and skin booster. Pictures show smooth skin but may not say what was applied or injected. The important question is not which abbreviation is popular. PDRN is not one standard facial: a cream, a superficial treatment or injections with different formulations and regulatory status can all appear under similar names.

Small clinical studies of injected polynucleotides suggest improvements in selected measures of skin texture or fine wrinkles, but the body of evidence remains limited and heterogeneous. That does not prove every PDRN cream works like the studied injections, or support promises of a facelift, filler replacement or complete scar removal. Before consenting, request the exact product name, composition, route of administration and official instructions for that product.

Are PDRN, PN and “salmon DNA” the same thing?

PDRN stands for polydeoxyribonucleotide: fragments of DNA chains. PN means polynucleotide and, in aesthetic practice, often denotes longer DNA fragments. Usage overlaps, and there is no universally accepted boundary between the two labels. Scientific reviews describe differences in molecular weight and physical properties, but proposed cut-offs should not be mistaken for international labeling standards.

“Salmon DNA” often refers to the source of starting material, not the concentration, purification, sterility, intended use or safety of the finished product. Similar-sounding products need not behave alike. Distinguish the ingredient from promotional language: the word “regeneration” in a serum description does not prove a clinically established effect on living human skin.

This matters when one provider offers “PDRN without needles”, another proposes a series of injections, and reviews treat both as identical. Duration, risks and session counts cannot be borrowed from a different preparation. Unlike the wider overview of polynucleotides and PDRN, this page focuses on decoding the labels and deciding what a specific “PDRN facial” means.

What might change—and what probably will not?

Small studies of injected PN have described changes in texture, elasticity or fine lines. A 2025 systematic review included nine studies involving 219 people and judged their quality low to moderate, calling for more rigorous trials. A subsequent systematic review of randomized trials, searching through January 2026, included seven trials with 183 participants, spanning rejuvenation, scars and wound healing rather than facial aesthetics alone. Formulations and outcomes differed, so the evidence supports cautious interest rather than predictable results. Some studies may appear in both reviews, so 219 and 183 must not be added together as though they were independent participant groups.

With aesthetic injections, the intended change is usually modest skin quality, not visibly added volume, changed expression or lifted tissue. Deep folds, excess skin, prominent jowls, pronounced nasolabial creases, true pigmented lesions or active skin disease are not automatically indications for PDRN. If you want the effect of a filler or botulinum toxin, first discuss how those treatments work differently.

Evidence is weaker still for topical serums. Studies of injected products cannot establish that large DNA fragments freely cross intact skin and remodel deeper tissue when simply spread on the surface. A cream's benefits may come from its moisturizing base, soothing ingredients and your broader routine. That does not make the cream worthless; it allows a more realistic purchase decision.

Do not treat medical wound-healing research as proof that a cosmetic preparation improves healthy facial skin. Individual formulations, concentrations and treatment sites require their own evidence; effects in one patient group may not occur in another. Ask which expected effects are supported by studies of the proposed product and which come from professional experience or marketing claims.

Who might consider it, and who should postpone?

An adult with a modest skin-quality concern, realistic expectations and no active inflammation may discuss a specific injectable with a clinician. Wanting to look “fresher” alone, however, does not make injections necessary. For dehydration, discomfort after harsh skincare or sensitive skin, gentler cleansing, moisturizer and sun protection are sensible first steps. This helps avoid confusing a short-lived skincare benefit with a need for an invasive treatment.

Active infection, inflamed lesions where needles would enter, broken skin, unexplained growths, a significant allergy history or previous injection complications require medical assessment first. With a fish allergy, neither automatic reassurance nor a blanket prohibition is sound: raw materials and purification differ, and contraindications depend on the particular product instructions and clinical assessment. Discuss reactions to the entire formula, including any anesthetic.

There is insufficient safety evidence to recommend elective aesthetic PDRN/PN injections in pregnancy or while breastfeeding; postponing them and discussing the issue with your clinician is reasonable. If you use anticoagulants or other medicines affecting clotting, have immune disorders or heal unusually, disclose this in advance. Never stop prescribed medicine on the advice of a beauty menu; that decision belongs with the prescribing clinician.

Injection plans around the eyes need particular care: delicate skin, blood vessels and nearby important structures make this a distinct anatomical area. Specific decisions are covered separately under PDRN injections under the eyes. If dark circles reflect an anatomical hollow, pigment or swelling, the name PDRN does not explain why it would help.

What happens during a session, and how painful is it?

First distinguish topical application from injection. A topical product may feel wet or cool or irritate you because of its ingredients; simple application does not leave needle marks. If microneedling, a roller or another puncturing technique is used, risks and recovery change even if the bottle says “serum”. Not every cosmetic product is suitable for delivery across a damaged barrier; that requires separate assessment of sterility and intended use.

For an injection procedure, the clinician should identify the product, assess your face, ask about previous procedures, explain the injection sites and describe what to do if complications arise. Many shallow punctures may leave small raised bumps called papules. Sensations range from a noticeable sting to pain in particular areas; local anesthesia depends on the product's instructions and your circumstances. No universal procedure length or compulsory course can be given without knowing the exact preparation.

Ask to see the original packaging, listed active ingredient, expiry date and instructions, and request evidence of sterility and batch traceability. Country of origin or sale does not document whether a product is legally injectable in this country and anatomical site. Registration in South Korea, the EU or the US does not automatically authorize use in Armenia; local paperwork must be checked before asserting availability or approval.

What will you look like after injections, and what recovery should you plan?

Socially visible marks are a different issue from being capable of doing daily tasks. You may work the next day and still have a bruise or swelling that colleagues notice. Before a wedding, travel or an important occasion, avoid scheduling your first injection experience right against the date. Ask your clinician about a realistic buffer for that protocol and decide whether you are comfortable with uncertainty.

Follow the treating clinician's written aftercare instructions: clean hands, gentle care of puncture sites, temporary avoidance of irritating products and caution with heat or strenuous exercise if advised. Do not massage the areas or attempt to “flatten” papules yourself. Makeup, shower, sport and skincare rules must not be copied from a different injectable product: they depend on technique and the condition of the skin.

How do ordinary reactions differ from warning signs?

Mild soreness, redness, swelling and bruising are possible after punctures. Increasing pain, spreading redness, warmth, pus or fever needs prompt medical assessment for possible infection or another complication. A sudden severe allergic reaction with breathing problems calls for emergency assistance.

Facial injections demand care around blood vessels. The US FDA describes a risk of accidental injection into vessels for dermal fillers, potentially injuring skin or vision. This does not establish an equal type or incidence of complications for PN/PDRN injections. Nevertheless, sudden unusually severe pain, white or mottled skin, vision changes or neurological symptoms during or following any facial injection justify immediate emergency evaluation, not waiting for bumps to disappear.

If a product is not hyaluronic acid, do not assume that it can be dissolved with hyaluronidase, an enzyme used in some complications involving HA fillers. “We can simply dissolve it if you dislike it” needs product-specific evidence. The practitioner should explain available responses to unwanted outcomes and access to urgent care.

When can you judge results, how many sessions, and how long will they last?

There is no shared evidence-based timetable for everything labeled PDRN: creams, injectable PN and combined skin boosters differ. Published trials use different courses, anatomical sites and follow-up intervals. The formula “three treatments, one year of results” is therefore not established for the entire category. Early swelling can make skin look temporarily fuller; do not mistake it for a long-term change in skin quality.

Agree on one or two concrete aims with the clinician, such as fine-line appearance or skin comfort, and document changes under matched lighting. Ask what would make you stop rather than continue a course. Little or no effect at an agreed checkpoint is a reason to revisit the goal, product or strategy—not automatically to buy another pack. Evidence does not justify a lifelong mandatory maintenance plan.

A natural-looking result may be a very slight change noticeable mainly to you. That can be attractive if you want your features to remain the same; it also means weighing cost, discomfort and injection risk against a potentially modest benefit. A non-invasive choice may suit you better even if it promises less.

What should you compare with a PDRN facial?

For dryness or irritation, start with barrier-friendly skincare, not needles. For superficial hydration, you can discuss skin boosters and biorevitalization separately, recognizing differences in products, indications and risk. For expression lines, botulinum toxin acts on muscles and is not a one-for-one alternative to PDRN. Persistent pigmentation, acne or vascular changes call for diagnosis and a targeted treatment plan.

Price cannot be judged by the brand alone. An itemized quote should specify product and amount, visits, any anesthesia, assessment, follow-up and the response to complications. Needing the protocol before giving a total estimate is understandable; requiring upfront purchase before explaining ingredients and limits is not. You can decline after the consultation.

Six questions that cut through the labels

1. Is this topical skincare, microneedling or an actual injection? What precisely happens to the skin?
2. What does the original label say about PN/PDRN, concentration, other ingredients, sterility and manufacturer?
3. What studies concern this formulation, site and schedule, rather than the category as a whole?
4. Is this use legal locally, and who is responsible for complications?
5. Which traces will be visible socially, and when must I seek urgent help?
6. What improvement can I reasonably expect, how will it be assessed, and what happens if there is no benefit?

If the only explanation is “it's natural DNA, so it is safe” or “everyone does it”, you do not have enough information for informed consent. You may request instructions, ask further questions, choose a simpler skincare routine or have no procedure at all.

A few additional questions

Does “salmon DNA” mean there are living cells or the patient's own genetic material in the product?

No. It generally refers to processed nucleic-acid fragments derived from a specified source. The exact finished formulation, processing and possible impurities must be checked in product documents.

Why might “under-eye” and “full-face” treatments cost different amounts and feel different?

These are distinct anatomical areas with different sensitivity, vessel distribution and technique requirements; price also depends on product and quantity. Cost alone proves neither safety nor effectiveness.

Sources

• The Effectiveness of Polynucleotides in Esthetic Medicine: systematic review, 2025.
• PN/PDRN for skin, scars and wound healing: systematic review of randomized trials, 2026.
• PN versus PDRN: molecular distinctions and clinical context, 2025.
• PN/PDRN terminology review, 2025 (proposed thresholds are not binding standards).
• FDA: dermal-filler risks (filler vascular events cannot simply be attributed to PDRN).
• CDC: signs of infection after a procedure.